Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 1 2Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Prostatic Neoplasms 3Multiple Myeloma 3Ovarian Neoplasms 2Neoplasms, Plasma Cell 2Mouth Neoplasms 2Head and Neck Neoplasms 2Weight Loss 1Urinary Bladder Neoplasms 1Tobacco Use Cessation 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Splenomegaly 1Smoking Cessation 1Neoplasm Metastasis 1Meningioma 1Lymphocytosis 1Lymphadenopathy 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Gynecologic Oncology Patient 1Gastrointestinal Neoplasms 1Fever 1Fatigue 1Fallopian Tube Neoplasms 1Depression 1Dental Caries 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

Paclitaxel 68Carboplatin 64pembrolizumab 32Cyclophosphamide 32Bevacizumab 27liposomal doxorubicin 24Cisplatin 24Topotecan 21Gemcitabine 21olaparib 18fludarabine 17Taxes 16Docetaxel 15Nivolumab 14Doxorubicin 14niraparib 13veliparib 12Albumin-Bound Paclitaxel 11aldesleukin 9Filgrastim 9fludarabine phosphate 8durvalumab 8Oxaliplatin 8Fluorouracil 8Drug Therapy 8sargramostim 7Peripheral Blood Stem Cell Transplantation 7Magnetic Resonance Spectroscopy 7Leucovorin 7talazoparib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Ovarian Neoplasms × Surveys and Questionnaires × Clear all
NCT00515372 2026-03-09

Depression Treatment and Screening in Ovarian Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
409 enrolled
Gynecologic

Depression, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02530047 2019-07-18

Mesenchymal Stem Cells (MSC) for Ovarian Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
5 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡